Author:
Şahin Ali,Özkan Tülin,Türkçapar Nuran,Küçükşahin Orhan,Köksoy Elif Berna,Özturk Gülşah,Erten Şükran,Sunguroğlu Asuman,Turgay Murat,Kınıklı Gülay
Reference39 articles.
1. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15(2):202–5.
2. Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med. 2009;360(19):1989–2003.
3. Ruzek MC, Jha S, Ledbetter S, Richards SM, Garman RD. A modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease. Arthritis Rheum. 2004;50(4):1319–31.
4. Jimenez SA. Artlett CM Microchimerism and systemic sclerosis. Curr Opin Rheumatol. 2005;17(1):86–90.
5. Lee ES, Bou-Gharios G, Seppanen E, Khosrotehrani K, Fisk NM. Fetal stem cell microchimerism: natural-born healers or killers? Mol Hum Reprod. 2010;16(11):869–78.